Caas Capital Management LP Kymera Therapeutics, Inc. Transaction History

Caas Capital Management LP

  • $552 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$35.64 - $85.46 $6.05 Million - $14.5 Million
-169,771 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$28.07 - $87.83 $4.05 Million - $12.7 Million
144,251 Added 565.25%
169,771 $10.5 Million
Q3 2020

Nov 09, 2020
BUY
$26.1 - $33.28 $666,072 - $849,305
25,520 New
25,520 $825,000

Others Institutions Holding KYMR

# of Institutions
181
Shares Held
64.3M
Call Options Held
50.6K
Put Options Held
81.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.11B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email